Mj. Lortie et al., AGMATINE, A BIOACTIVE METABOLITE OF ARGININE - PRODUCTION, DEGRADATION, AND FUNCTIONAL-EFFECTS IN THE KIDNEY OF THE RAT, The Journal of clinical investigation, 97(2), 1996, pp. 413-420
Until recently, conversion of arginine to agmatine by arginine decarbo
xylase (ADC) was considered important only in plants and bacteria. In
the following, we demonstrate ADC activity in the membrane-enriched fr
action of brain, liver, and kidney cortex and medulla by radiochemical
assay. Diamine oxidase, an enzyme shown here to metabolize agmatine,
was localized by immunohistochemistry in kidney glomeruli and other no
nrenal cells. Production of labeled agmatine, citrulline, and ornithin
e from [H-3]arginine was demonstrated and endogenous agmatine levels (
10(-6) M) in plasma ultrafiltrate and kidney were measured by HPLC. Mi
croperfusion of agmatine into renal interstitium and into the urinary
space of surface glomeruli of Wistar-Fromter rats produced reversible
increases in nephron filtration rate (SNGFR) and absolute proximal rea
bsorption (APR). Renal denervation did not alter SNGFR effects but pre
vented APR changes. Yohimbine (an alpha(2) antagonist) microperfusion
into the urinary space produced opposite effects to that of agmatine.
Microperfusion of urinary space with BU-224 (mu M), a synthetic imidaz
oline(2) (I-2) agonist, duplicated agmatine effects on SNGFR but not A
PR whereas an I-1 agonist had no effect. Agmatine effects on SNGFR and
APR are not only dissociable but appear to be mediated by different m
echanisms. The production and degradation of this biologically active
substance derived from arginine constitutes a novel endogenous regulat
ory system in the kidney.